Nucleolar Stress Induction by Oxaliplatin and Derivatives

J Am Chem Soc. 2019 Nov 20;141(46):18411-18415. doi: 10.1021/jacs.9b10319. Epub 2019 Nov 8.

Abstract

Platinum(II) compounds are a critical class of chemotherapeutic agents. Recent studies have highlighted the ability of a subset of Pt(II) compounds, including oxaliplatin but not cisplatin, to induce cytotoxicity via nucleolar stress rather than a canonical DNA damage response. In this study, influential properties of Pt(II) compounds were investigated using redistribution of nucleophosmin (NPM1) as a marker of nucleolar stress. NPM1 assays were coupled to calculated and measured properties such as compound size and hydrophobicity. The oxalate leaving group of oxaliplatin is not required for NPM1 redistribution. Interestingly, although changes in diaminocyclohexane (DACH) ligand ring size and aromaticity can be tolerated, ring orientation appears important for stress induction. The specificity of ligand requirements provides insight into the striking ability of only certain Pt(II) compounds to activate nucleolar processes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • A549 Cells
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology*
  • Cell Nucleus / drug effects*
  • Cell Nucleus / metabolism
  • Cell Nucleus / pathology
  • Cisplatin / pharmacology
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Nuclear Proteins / analysis
  • Nuclear Proteins / metabolism*
  • Nucleophosmin
  • Oxaliplatin / analogs & derivatives*
  • Oxaliplatin / pharmacology*

Substances

  • Antineoplastic Agents
  • NPM1 protein, human
  • Nuclear Proteins
  • Oxaliplatin
  • Nucleophosmin
  • Cisplatin